Venu Thatikonda
BioScientia (Poland)(PL)Boehringer Ingelheim (Austria)(AT)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Glioma Diagnosis and Treatment, Histone Deacetylase Inhibitors Research, Genomics and Chromatin Dynamics, Epigenetics and DNA Methylation
Most-Cited Works
- → Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling(2018)134 cited
- → A subtype of cancer-associated fibroblasts with lower expression of alpha-smooth muscle actin suppresses stemness through BMP4 in oral carcinoma(2018)94 cited
- → Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers(2023)93 cited
- → Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma(2020)70 cited
- → Interrogation of cancer gene dependencies reveals paralog interactions of autosome and sex chromosome-encoded genes(2022)58 cited
- → Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma(2018)45 cited
- → Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance(2024)38 cited
- → Two novel cell culture models of buccal mucosal oral cancer from patients with no risk-habits of tobacco smoking or chewing(2020)18 cited
- → Combined KRAS G12C and SOS1 inhibition enhances and extends the anti-tumor response in KRAS G12C -driven cancers by addressing intrinsic and acquired resistance(2023)17 cited
- → Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors(2018)12 cited